title: Insidious weight gain in prepubertal seized rats treated with an atypical neuroleptic: the role of food consumption, fluid consumption, and spontaneous ambulatory activity.
abstract: Extreme obesity slowly develops in female rats over the months following seizures induced by a single systemic injection of lithium and pilocarpine if the resulting limbic seizures are treated with the atypical neuroleptic acepromazine (but not with ketamine). To discern the contributions from food consumption, water consumption, and (daytime and nighttime) activity to this weight gain, these behaviors were monitored for 4 months, about 2 months after seizure induction. The results indicated that the rats that underwent the obesity procedure exhibited 50% heavier body weights and consumed 42% more food than the reference group, which included rats that had been induced to seize but treated with ketamine. There were no statistically significant differences between groups with respect to either water consumption or (daytime or nighttime) activity. Factor analyses of data for individual rats verified the dissociation between activity and weight gain for the obese rats. The results suggest that the progressive weight gains are centrally mediated and are not secondary to diminished activity or altered fluid consumption.
authors.affiliation: Department of Biology, Laurentian University, Sudbury, Ontario, Canada.
authors.forename: L S
authors.initials: LS
authors.lastname: St-Pierre
authors.forename: G A
authors.initials: GA
authors.lastname: Bubenik
authors.forename: G H
authors.initials: GH
authors.lastname: Parker
authors.forename: M A
authors.initials: MA
authors.lastname: Persinger
mesh_terms: D000075:Acepromazine / Q000494:pharmacology / Q000627:therapeutic use*; D000704:Analysis of Variance; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D004195:Disease Models, Animal; D004326:Drinking / Q000187:drug effects; D004435:Eating / Q000187:drug effects / Q000502:physiology; D004827:Epilepsy / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology*; D005260:Female; D018021:Lithium Chloride; D009765:Obesity / Q000139:chemically induced* / Q000503:physiopathology; D010862:Pilocarpine; D051381:Rats; D017208:Rats, Wistar; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D014150:Antipsychotic Agents; D010862:Pilocarpine; D000075:Acepromazine; D018021:Lithium Chloride